Respiratory

There are significant racial and socioeconomic disparities to consider when assessing adolescent asthma outcomes, especially since approximately 50% of adolescents with asthma-like symptoms go undiagnosed.

Studies presented at American Thoracic Society 2018 International Conference looked at video-assisted thoracoscopic surgery and drug resistance mutations in nontuberculous mycobacterial lung disease.

While knowledge and care for children with asthma has increased over time, overall morbidity has not decreased. A new study evaluated which interventions were effective at the point of discharge from the hospital to prevent readmission.

Non-tuberculous mycobacterium (NTM), a serious lung disease, can be identified in different ways in patients. Recently, 2 studies evaluated specific identification and causes of NTM in order to help predict treatment outcomes in the future.

Mines that are in compliance with the Mine Safety and Health Administration's requirements experience significantly lower lung disease cases over time compared with mines not in compliance. However, the lung disease burden among the coal mining industry has increased in the last decade.

A study found the use of interprofessional education improves students' knowledge and skill sets and promotes collaborative behaviors.

The Institute for Clinical and Economic Review (ICER) released a draft scoping document on new biologics for severe asthma. Public comment on the draft is open until June 5.

A new study published in JAMA showed that although estimates of prescription medication use for children and teens fell overall from 1999 to 2014, patterns differed by types of medications, with drugs for attention-deficit/hyperactivity disorder (ADHD), asthma, and contraception all increasing. Use of antibiotics, antihistamines, and upper respiratory combination medications decreased.

The FDA Wednesday confirmed that there are “intermittent” shortages of Mylan’s EpiPen, an autoinjector device containing epinephrine to counteract the effects of anaphylaxis, but said it expects the delay to be short, while the manufacturer said the issue has to do with supply of third-party components.

Ivacaftor, the first drug that targeted the underlying defect of cystic fibrosis (CF), which affects about 30,000 people in the United States, improved outcomes and reduced hospitalizations, according to an analysis in the May issue of Health Affairs examining precision medicine.

Exposure to a short-term increase in pollution-causing airborne particles called fine particulate matter 2.5 is linked to the development of acute lower respiratory infection in young children, as well as additional doctor visits, according to new research.

Allergic diseases such as asthma were associated with a 1.66-fold increased hazard of psychiatric disorders in Taiwan, according to a large study published in Frontiers in Psychiatry.

The FDA and the FTC issued 13 warning letters Tuesday to manufacturers, distributors, and retailers for selling e-liquids used in e-cigarettes, or vaping devices, with labeling or advertising that bears stark resemblances to kid-friendly food products, such as juice boxes, candy, or cookies.

The Institute for Clinical and Economic Review (ICER) is going to review the class of biologic drugs used to treat moderate to severe eosinophilic asthma and release a report in November, the organization said.

Researchers from Mexico recommend conducting a pulmonary function test in patients with non–small cell lung cancer (NSCLC) undergoing concurrent chemoradiotherapy to assess their susceptibility to developing radiation pneumonitis.

A DNA test method called polymerase chain reaction can shave days off the time it takes to detect a Legionnaires' disease outbreak to mere hours and should be implemented by health departments to prevent illness, a new study reported.

Using statewide quality data for medical home–eligible clinics, we tested asthma education as a clinical mechanism whereby medical homes achieve better asthma outcomes.

A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.

Respimat from Boehringer Ingelheim is now the first and only inhaler to be awarded the Ease of Use Commendation by the Arthritis Foundation. This award identifies products that make life easier for people with arthritis and other physical limitations.

Cigarette smoking is the most common cause of chronic obstructive pulmonary disease (COPD), but not all smokers develop the condition, and many non-smokers do. Why that is has remained a mystery until now, as a research team, funded by the National Institutes of Health, has discovered genetic variations in the anatomy of the lungs could serve as early-warning indicators.

Asthma costs the U.S. economy more than $80 billion annually in medical expenses, days missed from work and school, and deaths, according to research published online in the Annals of the American Thoracic Society. However, actual numbers are likely to be higher, according to CDC researchers who conducted the study.

Psychological factors negatively affect quality-of-life scores in chronic obstructive pulmonary disease (COPD) patients, according to a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.

Patients with chronic obstructive pulmonary disease should be given the pneumococcal conjugate vaccine and influenza vaccines to decrease the risk of exacerbations. However, despite the evidence of vaccine efficacy, improvements are needed in coverage and awareness.

Less than 10% of patients with chronic obstructive pulmonary disease (COPD) who may benefit from pulmonary rehabilitation received a referral from their physician, according to a new study. However, there was no association found between referral status and COPD exacerbations.

The FDA has removed a boxed warning on medicines delivering a combinations of inhaled corticosteroid (ICS) and long-acting beta agonists (LABA) drugs.

Despite effective pharmacology, many patients with asthma have impaired quality of life, but a new breathing retraining intervention can be used as a nonpharmacological intervention to treat asthma.

The FDA has announced its launch of the “Every Try Counts” campaign, which will encourage smokers to quit by advertising messages of support underscoring the health benefits of quitting. The campaign will also focus on celebrating each quit attempt as a step towards success.

Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.

A study of patients with severe chronic obstructive pulmonary disease (COPD) in Poland, The Republic of Korea, and the United States identified substantial differences in respiratory symptoms and other respiratory illnesses.

High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.